| RS2503543085 |
ORAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, tubular aggregate |
| RS2503543510 |
ORAI1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to ORAI1 deficiency, Myopathy |
| RS2503544532 |
ORAI1
|
Health Risk |
Likely pathogenic |
— |
| RS2503547380 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2503548183 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2503548478 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2503548576 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2503549007 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2503550047 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS2503562017 |
TMEM260
|
Health Risk |
Pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS2503565184 |
DDHD1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 28, Hereditary spastic paraplegia 28 |
| RS2503570171 |
SPTLC2
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2503574858 |
DDHD1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 28, Hereditary spastic paraplegia 28 |
| RS2503578399 |
NBEA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2503581243 |
NALCN
|
Health Risk |
Pathogenic |
— |
| RS2503592299 |
NBEA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2503604772 |
TMEM260
|
Health Risk |
Pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS2503605066 |
SIX6
|
Health Risk |
Likely pathogenic |
— |
| RS2503608451 |
TSHR
|
Health Risk |
Likely pathogenic |
— |
| RS2503608613 |
TSHR
|
Health Risk |
Likely pathogenic |
TSHR-related disorder, TSHR-related disorder |
| RS2503617333 |
CIROP
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS2503620997 |
NBEA
|
Health Risk |
Likely pathogenic |
NBEA-related disorder, NBEA-related disorder |
| RS2503622228 |
NBEA
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2503626360 |
NBEA
|
Health Risk |
Pathogenic |
— |
| RS2503634132 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2503635511 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503635576 |
BCL11B
|
Health Risk |
Likely pathogenic |
BCL11B-related disorder, BCL11B-related disorder |
| RS2503635965 |
BCL11B
|
Health Risk |
Likely pathogenic |
— |
| RS2503636070 |
BCL11B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503636087 |
BCL11B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503636657 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503639083 |
NBEA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2503640330 |
NBEA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2503641685 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503643685 |
DLK1
|
Health Risk |
Likely pathogenic |
Central precocious puberty, Central precocious puberty |
| RS2503644647 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503645451 |
BCL11B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503648198 |
BCL11B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503648320 |
BCL11B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503652316 |
BCL11B
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2503652732 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS2503654780 |
TMEM260
|
Health Risk |
Pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS2503665263 |
NBEA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2503672265 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503693934 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503696010 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503708532 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503714640 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
DYNC1H1-related disorder, DYNC1H1-related disorder |
| RS2503714657 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Intellectual disability |
| RS2503714817 |
DYNC1H1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503715379 |
DYNC1H1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503715383 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503720187 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures, Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures |
| RS2503721224 |
TSHR
|
Health Risk |
Pathogenic |
— |
| RS2503726588 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
DYNC1H1-related disorder, DYNC1H1-related disorder |
| RS2503727339 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503727356 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503730449 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503731165 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2503734461 |
DYNC1H1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503742080 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503746851 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS2503746947 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS2503747057 |
CDC42BPB
|
Health Risk |
Likely pathogenic |
Chilton-Okur-Chung neurodevelopmental syndrome, Chilton-Okur-Chung neurodevelopmental syndrome |
| RS2503750754 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
DYNC1H1-related disorder, DYNC1H1-related disorder |
| RS2503750846 |
DYNC1H1
|
Health Risk |
Pathogenic |
— |
| RS2503751017 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures, Intellectual disability |
| RS2503751910 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503757710 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503757868 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503773145 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS2503780305 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503792325 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503792540 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503797582 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis |
| RS2503797952 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503798515 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503798936 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503799127 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503804130 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503805285 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS2503806504 |
DYNC1H1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503812014 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503812445 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503823659 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
— |
| RS2503824109 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS2503825876 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
DYNC1H1-related disorder, Inborn genetic diseases |
| RS2503831353 |
RDH12
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503832440 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503833008 |
RDH12
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2503833321 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503833731 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503833934 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503834681 |
BCL11B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with speech delay, dysmorphic facies |
| RS2503843400 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2503844415 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503844606 |
NBEA
|
Health Risk |
Pathogenic |
— |
| RS2503844940 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS2503871450 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS2503871870 |
RDH12
|
Health Risk |
Likely pathogenic |
RDH12-related disorder, RDH12-related disorder |